Asklepios BioPharmaceutical, Inc. (AskBio) is a leading, clinical-stage gene therapy company founded in 2001 based on the work of adeno-associated virus (AAV) gene therapy visionary and pioneer, Jude Samulski, PhD. Since that time, our commitment to developing life-saving medicines that can potentially cure genetic diseases has never wavered. At AskBio, we’ve built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson’s disease, and congestive heart failure. Our gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library. We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, and Spain. Our vision: Pioneering science to create transformative molecular medicines. Our mission: Lead innovative science and drive clinical outcomes to transform people's lives. Our principles: Advance innovative science by pushing boundaries. Bring transformative therapeutics to patients in need. Provide an environment for employees to reach their fullest potential. Our values: Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through. The Role The Vice President (VP), Neuromuscular Clinical Development, reporting to the Head Clinical Development with a dotted line to the Integrated Product Team (IPT) Leader for AskBio’s Neuromuscular programs, will be responsible for developing and implementing the IPT’s clinical development strategy for clinical programs spanning all stages of product development. As a core member of the global Clinical Development organization and Neuromuscular IPT, the VP for Neuromuscular Clinical Development will work with all members of the IPT including Scientific Chair, IPT Leader, Program Manager, and functional leads for Clinical Operations, Regulatory Affairs, Medical Affairs, Commercial, Nonclinical, Drug Delivery and CMC. The incumbent will be responsible for establishing and overseeing global clinical development strategies in alignment with the company’s mission and values that will support regulatory approval and commercial launches in multiple territories including the US, EU and UK. He or she will build and manage a team of medical directors and provide leadership as co-chair of the IPT’s Clinical Sub-team in collaboration with their co-chair VP, Neuromuscular Clinical Operations. The Clinical Sub-team provides oversight of clinical research activities, including development of core documents such as clinical development plans, investigator brochures, clinical trial protocols, statistical analysis plans, clinical study reports, and regulatory filings to meet program timelines. As a senior leader of the Clinical Development organization, the VP for Neuromuscular Clinical Development is expected to provide insights and expertise to other IPTs and serve as a core member of the Protocol Review Committee at AskBio. The VP, Neuromuscular Clinical Development will partner with AskBio’s Safety and Pharmacovigilance teams to oversee medical monitoring and drug safety reporting, and will work closely with the Clinical Operations, Regulatory, Medical Affairs and Patient Advocacy teams on clinical study planning and resource management to execute global clinical studies. Furthermore, he or she will be positioned to expand and support the company’s global relationships with clinical sites, investigators, patient and community organizations, internal functional teams, and third-party vendors. Responsibilities & Accountabilities Provide strategic clinical development leadership to AskBio’s Neuromuscular IPT, working to secure cross-functional alignment via active and transparent discussions. Recruit, lead, and mentor a team of development physicians and clinical scientists. Partner with the IPT to source clinical, biostatistics and KOL support. Contribute to development and execution of the clinical strategy, ensuring that the overall scientific and medical content of each clinical study is scientifically rigorous, cost-effective sound and designed for success. Proactively work to identify clinical risks and implement risk mitigation strategies. Provide input to CDP development, in line with the Target Product Profile (TPP), for successful global regulatory approvals and market access. Partner with IPT colleagues (including Clinical Operations, Medical Affairs, Commercial, Nonclinical, Drug Delivery and CMC) and other functional leaders to design, execute and report clinical trials. Partner with Clinical Operations to co-chair the Clinical IPT Subteam to provide medical oversight of study design and execution, assure timely initiation of studies, support recruitment and retention activities, and achieve program milestones on time and within budget. Manage the creation and maintenance of critical study documents assigned to Clinical Development (e.g., Clinical Trial Protocols (CTPs), Investigator’s Brochures (IB), Informed Consent Forms (ICF), Risk-Based Medical Monitoring Plan, Clinical Study Reports (CSRs), regulatory documents) with high quality and consistency with CDP, TPP and AskBio SOPs. Partner with Pharmacovigilance and Safety colleagues to provide continuous evaluation of drug safety profile, including safety monitoring of clinical studies and signal detection from post-marketing surveillance. May serve as a core member of the Safety Management Team (SMT) Lead the Neuromuscular Clinical Development team during interactions regarding drug development, safety, marketing, regulatory filing, and other aspects of a Neuromuscular gene therapy product life cycle As the medical expert, participate in interactions with external stakeholders (e.g., regulatory authorities, KOLs, Data Monitoring Committee (DMC), advisory boards, patient advocacy groups) Work collaboratively to prepare and present abstracts, manuscripts and presentations for external meetings and publications. May support technical due diligence in Business Development & Licensing (BD&L) activities. About you MD, DO or equivalent (based on the current World Directory of Medical Schools) is required; specialty training, patient care, and/or extensive drug development experience in neuromuscular diseases strongly preferred At least 10 years of clinical development experience in an industry environment spanning clinical activities in Phases I through III/IV is required Strong track record and demonstrated excellence in IND/NDA/BLA submissions and approvals Advanced clinical training/knowledge or clinical research experience in a medical/scientific area, preferably aligned with AskBio’s focused therapeutic areas (cardiovascular, CNS, neuromuscular, metabolic, and genetic disorders) is preferred In-depth knowledge of ICH-GCP, clinical trial design, statistics, and regulatory/clinical development process Demonstrated ability to establish strong scientific partnership with internal and external key stakeholders Demonstrated strong leadership and effective communication skills with a documented record of delivering high quality projects/submissions/trials in a global/matrix environment in pharmaceutical or biotech industry or academia or clinical CRO is required Firsthand experience in organizing and managing scientific or clinical advisory boards Advanced knowledge in gene therapy, training or experience in neurosciences with the capability to innovate in clinical development study designs that provide robust clinical evidence to internal decision-makers and regulatory agencies is preferred Experience in hiring, mentoring, and retaining clinical development/medical directors or scientists is a strong plus Asklepios BioPharmaceutical, Inc. (AskBio) is an Equal Opportunity Employer and does not discriminate against any employee or applicant for employment because of race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or any other protected status prohibited under Federal, State or local laws. All employment decisions are based on valid job‐related requirements. If you are a qualified individual with a disability or a disabled veteran and are unable or limited in your ability to use or access our website, you may request a reasonable accommodation to express interest in a specific opening by calling us at (919) 561-6210 or sending us an email at careers@askbio.com. Agencies: Please do not contact any employee at AskBio about this requisition. Any resume submitted by a recruitment agency to any employee at AskBio, through any medium, will be deemed the sole property of AskBio unless the agency was engaged by AskBio Talent Acquisition team to recruit for that position. All agencies must have a prior executed service agreement with AskBio prior to any search engagement. If a candidate who was submitted outside of the AskBio agency process is hired by AskBio, no fee or payment of any kind will be paid to the agency. Asklepios BioPharmaceutical, Inc. (AskBio) is a leading, clinical-stage gene therapy company founded in 2001 based on the work of adeno-associated virus (AAV) gene therapy visionary and pioneer, Jude Samulski, PhD. Since that time, our commitment to developing life-saving medicines that can potentially cure genetic diseases has never wavered. At AskBio, we’ve built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson’s disease, and congestive heart failure. Our gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library. We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, and Spain.